Home›People›Richard Morris
Richard Morris

Richard Morris

CFO at Averna Therapeutics.

Executive
Updated Nov 10, 2026·Latest SEC filing Mar 20, 2026·Suggest an edit

About Richard Morris

Richard Morris is CFO at Averna Therapeutics.

Experience

This experience comes from Richard Morris's profile and from SEC filings. For roles taken from filings, the years are when the filings name Richard Morris in the role, so the role may have started earlier or lasted longer.

Averna Therapeutics Inc. Current
Chief Financial Officer
2026 – Present · Watertown, MA
Develops gene insertion medicines for people with genetic diseases, cancer and autoimmune conditions.
Carisma Therapeutics
Chief Financial Officer
2021 – 2024
Passage Bio
Chief Financial Officer
2019 – 2021
Context Therapeutics
Executive Vice President and Chief Financial Officer
2017 – 2019
Vitae Pharmaceuticals
Chief Financial Officer
2014 – 2016
Comcast
Manager of New Business Development
2000 – 2001
KPMG Audit
Supervising Senior - Life Science Practice
1996 – 2000

Key Colleagues at Startups

The people Richard Morris works with at each company, as listed on that company's latest Form D.

Averna Therapeutics Inc. · Form D/A, Mar 20, 2026
Thomas Barnes
Thomas Barnes
CEO & Board Member
Roy Amariglio
Roy Amariglio
Board Member
Nick Olsen
Nick Olsen
Board Member
SS
Raju Prasad
Raju Prasad
Board Member
Tal Zaks
Tal Zaks
Executive Chairman of the Board
Henry Chen
Henry Chen
Board Member
DM
Dylan Morris
Board Member

Sources

  1. SECAverna Therapeutics Inc. Form D/A, filed Mar 20, 2026